Search Names & Symbols
With personal love and passion we work alone and analyze our favorite shares. May not be many, but they are worth it.
DISCLAIMER:
The financial and technical analycies presented on this website have not been performed by an Investment Services Company, nor have they been compiled by a certified analyst . It is simply a display and presentation of public data of Greek and foreign shares with informative and entertaining character.
Thursday, February 17, 2022
OPAP: the VALEA FOUNDATION, and the entities controlled by, and acting in concert with, VALEA FOUNDATION and following SAZKA Group a.s.’ acquisitions from the market since 16 December 2021, indirectly control in total 48.09% of the total share capital and voting rights in OPAP
17/02/2022
SAZKA Entertainment AG operating under the brand name Allwyn (“Allwyn”) today announced that RUBIDIUM HOLDINGS LIMITED (“Rubidium”) through which Allwyn indirectly holds non-voting shares of OPAP S.A. (“OPAP”) reached an agreement with Yeonama Holdings Co. Limited (“Yeonama”) to purchase the remaining minority non-voting shares of Yeonama in SAZKA Delta AIF Variable Investment Company Ltd (“SAZKA Delta”), an entity through which Allwyn holds part of its interest in OPAP for consideration of €327.4 million (the “Transaction”). As a result, Allwyn’s economic interest (i.e. the percentage representing, regardless of control of SAZKA Delta, the participation in distributions but not the voting rights) in OPAP will increase from approximately 41.2% to approximately 48.1%. It is reminded that reference to the non-voting shares held by Yeonama was made in the Information Memorandum in relation to the voluntary tender offer launched by SAZKA Group a.s., which has been approved by the HCMC on 30 September 2019.
Taking into account the net debt and working capital of SAZKA Delta, the Transaction implies a premium of more than 10% on OPAP’s current market share price. The purchase price will be financed with cash from the balance sheet, including cash raised by the recent €600 million bond issuance.
The Transaction has no impact on the sole control exercised by VALEA FOUNDATION over SAZKA Delta, and thus no impact on the number and percentage of shares and voting rights in OPAP indirectly controlled by VALEA FOUNDATION and the entities controlled by, and acting in concert with, VALEA FOUNDATION within the meaning of Law 3556/2007, which according to latest TR-1 notification by VALEA FOUNDATION dated 7 January 2022 was equal to 47.13% as of 16 December 2021.
As of today the VALEA FOUNDATION, and the entities controlled by, and acting in concert with, VALEA FOUNDATION and following SAZKA Group a.s.’ acquisitions from the market since 16 December 2021, indirectly control in total 48.09% of the total share capital and voting rights in OPAP, as follows:
Corporate Name
Percentage
VALEA FOUNDATION
48.09
Valea Holding AG
48.09
KKCG Holding AG
48.09
KKCG AG
48.09
SAZKA Entertainment AG
48.09
SAZKA Group a.s.
48.09
Sazka Delta Management Ltd. (formerly Emma Delta Management Ltd.)
48.09
SAZKA Delta AIF Variable Capital Investment Company Ltd. (formerly Emma Delta Variable Capital Investment Company Ltd.)
48.09
SAZKA Delta Hellenic Holdings Limited (formerly Emma Delta Hellenic Holdings Limited)
48.09
Bayer highlights advancements of agriculture industry’s most prolific R&D pipeline
Crop Science R&D Pipeline Update 2022
Bayer highlights advancements of agriculture industry’s most prolific R&D pipelineIndustry-leading investment expected to translate to nearly €30bn peak sales potential / Game-changing Short Stature Corn advances, readying for 2023 commercial trials / More than 500 new high-performing seed hybrids and varieties deployed and greater than 300 new registrations refresh crop protection portfolio / Digital transformation well underway as Climate FieldView™ reaches more than 180 million acres; unlocks climate-smart models with expansion of Bayer Carbon Initiative
Bayer showcases the latest in crop protection, seeds & traits and digital solutions. ...
Wednesday, February 16, 2022
Tuesday, February 15, 2022
Monday, February 14, 2022
BDSI 52 WEEK HIGH
BioDelivery Sciences International (BDSI) 52 WEEK HIGH
Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal
Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction...
Sunday, February 13, 2022
The shares of our page with the best and worst performance of the week
The financial and technical analycies presented on this website have not been performed by an Investment Services Company, nor have they been compiled by a certified analyst . It is simply a display and presentation of public data of Greek and foreign shares with informative and entertaining character.
Corsair Gaming, Inc.
FREEDOME 24
After opening an account, you will receive a free share worth up to $ 600
COMPANY OF THE WEEK: Mytilineos (MYTIL.AT)
European Reliance: ANNOUNCEMENT FOR IMPORTANT EVENTS
ANNOUNCEMENT FOR IMPORTANT EVENTS
Today, the Offeror executed share purchase agreements with Company’s shareholders for the acquisition of 19.181.256 shares before the end of the Tender Offer Acceptance Period, which represent in total 72,2% of the shares and voting rights in the Company, subject to approvals required by the competent regulatory authorities, the Bank of Greece, the Hellenic Capital Market Commission and the Hellenic Competition Commission (hereinafter the Transaction). In particular the Offeror has executed share purchase agreements with the following:
1. shareholders of the Company, including Company’s executives and the CEO, for the acquisition of 5.313.400 shares representing 20.02% of shares and voting rights in the Company;
2. EBRD, for the acquisition of 4.125.552 shares representing 15.54% of shares and voting rights in the Company; and
3. other shareholders, for the acquisition of 9.742.304 shares representing 36.7% of shares and voting rights in the Company.
The long term plans of the Offeror include the integration of Company's activities with those of the Allianz Group's subsidiary in Greece with Mr. Christos Georgakopoulos as CEO, the promotion of the Company's brands and the strengthening of the Allianz Group’s role in the Greek insurance market.
The proposed participation of the Offeror in the Company's share capital and the fact that Mr. Christos Georgakopoulos shall remain in the Company's management will ensure the continuation of the Company's business strategy and operation under the same successful business principles, but will also result in achieving additional benefits which will arise from the Company's participation in a global group operating in the same sector, thus contributing to the further strengthening of the Company's position in the market.
Alphacap acts as financial advisor and law firm Zepos & Yannopoulos acts as legal advisor in relation to the Transaction.
Subscribe to:
Posts (Atom)